Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Factors Associated with MASLD Resilience in Type 2 Diabetes: A Prospective Study Integrating Longitudinal MRI/MRE Imaging and Stable Isotope Tracing
Federica Tavaglione, Veeral Ajmera, Luis Antonio Diaz, Kelvin Li, Egbert Madamba, Ricki Bettencourt, Lisa Richards, Marc Hellerstein, Rohit Loomba (2026). Factors Associated with MASLD Resilience in Type 2 Diabetes: A Prospective Study Integrating Longitudinal MRI/MRE Imaging and Stable Isotope Tracing. , DOI: https://doi.org/10.1016/j.jhepr.2026.101733.
Article11 days agoIdentifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood
Martin Decaris, Kelvin W. Li, Claire Emson, Michelle Gatmaitan, Shanshan Liu, Yenny Wang, Edna Nyangau, Marc Colangelo, Thomas E. Angel, Carine Beysen, Jeffrey Cui, Carolyn Hernandez, Len Lazaro, David A. Brenner, Scott Turner, Marc Hellerstein, Rohit Loomba (2016). Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood. , 65(1), DOI: https://doi.org/10.1002/hep.28860.
Article11 days agoSAT-352-A combination of the ACC inhibitor GS-0976 and the nonsteroidal FXR agonist GS-9674 improves hepatic steatosis, biochemistry, and stiffness in patients with non-alcoholic steatohepatitis
Eric Lawitz, Edward Gane, Peter Ruane, Robert Herring, Ziad Younes, Paul Y. Kwo, Jie Zhang, Catherine Jia, Jay Chuang, B. Mccolgan, Chuhan Chung, Mani Subramanian, Robert P. Myers, Michael S. Middleton, Kelvin W. Li, Marc Hellerstein, Mazen Noureddin, Stephen A. Harrison, Rohit Loomba (2019). SAT-352-A combination of the ACC inhibitor GS-0976 and the nonsteroidal FXR agonist GS-9674 improves hepatic steatosis, biochemistry, and stiffness in patients with non-alcoholic steatohepatitis. , 70(1), DOI: https://doi.org/10.1016/s0618-8278(19)31582-8.
Article11 days agoAcetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis
Eric Lawitz, Angie Coste, Fred Poordad, Naim Alkhouri, Nicole Loo, B. Mccolgan, Jacqueline M. Tarrant, Tuan Nguyen, Ling Han, Chuhan Chung, Adrian S. Ray, John G. McHutchison, G. Mani Subramanian, Robert P. Myers, Michael S. Middleton, Claude B. Sirlin, Rohit Loomba, Edna Nyangau, Mark Fitch, Kelvin W. Li, Marc Hellerstein (2018). Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis. , 16(12), DOI: https://doi.org/10.1016/j.cgh.2018.04.042.
Article11 days agoDiscovery of Half-life of Circulating Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B Infection Using Heavy Water Labeling
Rohit Loomba, Martin Decaris, Kelvin W. Li, Mahalakshmi Shankaran, Hussein Mohammed, Marcy Matthews, Lisa Richards, Phirum Nguyen, Emily Rizo, Barbara Andrews, R Soto, Thomas E. Angel, Vithika Suri, Kathryn M. Kitrinos, Dwight Barnes, Gregg Czerwieniec, Kathy Brendza, G. Mani Subramanian, Anuj Gaggar, Marc Hellerstein (2018). Discovery of Half-life of Circulating Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B Infection Using Heavy Water Labeling. , 69(3), DOI: https://doi.org/10.1093/cid/ciy1100.
Article11 days ago